Cargando…

11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome

CONTEXT: Androgen excess is a defining feature of polycystic ovary syndrome (PCOS), but the exact origin of hyperandrogenemia remains a matter of debate. Recent studies have highlighted the importance of the 11-oxygenated C19 steroid pathway to androgen metabolism in humans. In this study, we analyz...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Reilly, Michael W., Kempegowda, Punith, Jenkinson, Carl, Taylor, Angela E., Quanson, Jonathan L., Storbeck, Karl-Heinz, Arlt, Wiebke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2016
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460696/ https://www.ncbi.nlm.nih.gov/pubmed/27901631 http://dx.doi.org/10.1210/jc.2016-3285

Ejemplares similares

Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
por: Kempegowda, Punith, et al.
Publicado: (2020)

Peripheral blood mononuclear cells preferentially activate 11-oxygenated androgens
por: Schiffer, Lina, et al.
Publicado: (2021)

MON-203 Local Activation of 11-Oxygenated Androgens by AKR1C3 Is the Predominant Source of Androgens in Human Female Adipose Tissue
por: Schiffer, Lina, et al.
Publicado: (2019)

MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease
por: Schiffer, Lina, et al.
Publicado: (2017)

AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome
por: O’Reilly, Michael W., et al.
Publicado: (2017)

Concerns and expectations in women with polycystic ovary syndrome vary across age and ethnicity: findings from PCOS Pearls Study
por: Elghobashy, Mirna, et al.
Publicado: (2023)

Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England
por: Subramanian, Anuradhaa, et al.
Publicado: (2022)

A systematic review of lived experiences of people with polycystic ovary syndrome highlights the need for holistic care and co-creation of educational resources
por: Lau, Gar Mun, et al.
Publicado: (2022)

11-Ketotestosterone and 11-Ketodihydrotestosterone in Castration Resistant Prostate Cancer: Potent Androgens Which Can No Longer Be Ignored
por: Pretorius, Elzette, et al.
Publicado: (2016)

Intracrine androgen biosynthesis, metabolism and action revisited
por: Schiffer, Lina, et al.
Publicado: (2018)

OR20-01 Machine Learning-based Steroid Metabolome Analysis In Women With Polycystic Ovary Syndrome Reveals Three Distinct Androgen Excess Subtypes With Different Metabolic Risk Profiles.
por: Rocha, Thaís P, et al.
Publicado: (2023)

Appraising Unmet Needs and Misinformation Spread About Polycystic Ovary Syndrome in 85,872 YouTube Comments Over 12 Years: Big Data Infodemiology Study
por: Malhotra, Kashish, et al.
Publicado: (2023)

11-Oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing’s disease
por: Nowotny, Hanna F, et al.
Publicado: (2022)

OR27-1 11-Oxygenated C19 Steroids Are the Predominant Androgens Responsible for Hyperandrogenemia in Cushing's Disease
por: Adaway, Jo, et al.
Publicado: (2022)

Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
por: Kumarendran, Balachandran, et al.
Publicado: (2018)

Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
por: O'Reilly, Michael W., et al.
Publicado: (2014)

11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration
por: Snaterse, Gido, et al.
Publicado: (2021)

Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study
por: Subramanian, Anuradhaa, et al.
Publicado: (2021)

A systematic review of models of care for polycystic ovary syndrome highlights the gap in the literature, especially in developing countries
por: Melson, Eka, et al.
Publicado: (2023)

Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review
por: Schiffer, Lina, et al.
Publicado: (2019)

Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study
por: Kumarendran, Balachandran, et al.
Publicado: (2019)

Improving emotional and psychosexual well-being screening in women living with polycystic ovary syndrome: experiences from the United Kingdom and India
por: Hebbar, Meghnaa, et al.
Publicado: (2023)

Elevated and diagnostic androgens of polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2020)

11-Oxygenated Estrogens Are a Novel Class of Human Estrogens but Do not Contribute to the Circulating Estrogen Pool
por: Barnard, Lise, et al.
Publicado: (2020)

Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
por: Storbeck, Karl-Heinz, et al.
Publicado: (2019)

SAT373 A Systematic Review and Meta-Analysis Show Body Image Concerns Are Significantly Higher in Women and Individuals With Polycystic Ovary Syndrome
por: Kempegowda, Punith, et al.
Publicado: (2023)

THU005 Patient And Public Involvement In Virtual Simulation-based Education Informs And Enhances Clinicians’ Knowledge In Managing Polycystic Ovary Syndrome And Adrenal Conditions
por: Pan, Carina S C, et al.
Publicado: (2023)

11β-Hydroxyandrostenedione Returns to the Steroid Arena: Biosynthesis, Metabolism and Function
por: Bloem, Liezl M., et al.
Publicado: (2013)

MON-040 11-Oxygenated C19 Steroids in Polycystic Ovarian Syndrome
por: Mody, Armaiti, et al.
Publicado: (2020)

The interplay between androgens and the immune response in polycystic ovary syndrome
por: Shabbir, Sania, et al.
Publicado: (2023)

Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
por: McDonnell, Tara, et al.
Publicado: (2022)

Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women
por: Elhassan, Yasir S, et al.
Publicado: (2018)

OR27-07 11-oxygenated C19 Steroids in Normal Weight, Overweight, and Hyperandrogenic Girls
por: Burt Solorzano, Christine Michele, et al.
Publicado: (2020)

SAT-LB002 Steroid Metabolome Analysis Reveals 11-Ketotestosterone as the Most Abundant Androgen in Castration-Resistant Prostate Cancer Patients on Second-Line Therapies
por: Snaterse, Gido, et al.
Publicado: (2019)

The Steroid Metabolome in the Isolated Ovarian Follicle and Its Response to Androgen Exposure and Antagonism
por: Lebbe, Marie, et al.
Publicado: (2017)

Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study
por: Kumarendran, Balachandran, et al.
Publicado: (2021)

Adrenal insufficiency from steroid-containing complementary therapy: importance of detailed history
por: Kempegowda, Punith, et al.
Publicado: (2019)

Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats
por: Wang, Fang, et al.
Publicado: (2012)

OR35-05 Interaction of Cortisol with Testosterone Predicts Abdominal Fat Mass in Normal-weight Polycystic Ovary Syndrome Women with Normal Serum 11-Oxygenated Androgens
por: Anthony Dumesic, Daniel, et al.
Publicado: (2023)

11-Oxyandrogens in Adolescents With Polycystic Ovary Syndrome
por: Taylor, Anya E, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vtpgifbjr3ilii90tnofr66lkg